3rd Annual Meeting of PASN – Tokyo

[ June 2008 ]

Tokyo, Japan
Leading researchers from research institutes in Asia, DNDi, and MMV met from 9th-11th June to share their vision to make Asia a major player in drug development for the neglected diseases, utilizing local natural resources. This meeting of PAN4ND was co-hosted by DNDi and the Kitasato Institute.

Stakeholder Meeting

[ June 26, 2008 ]
New York, USA
DNDi’s First Stakeholders’ meeting took place on 26th June in New York and brought together 150 scientists, researchers, academics, and global health leaders from 25 countries to discuss how international research partnerships can best develop and deliver new lifesaving  drugs for neglected diseases.

ASMQ Launch

[ April 2008 ]
Rio de Janeiro, Brazil
Farmanguinhos/Fiocruz and DNDi launched ASMQ, the new fixed-dose combination of artesunate (AS) and mefloquine (MQ), now registered in Brazil. Developed and delivered by a worldwide collaboration of public partners, ASMQ will soon be available throughout Latin American and Southeast Asia.

10th Leishmaniasis East Africa Platform (LEAP) – Sudan

[ February 2008 ]
Sudan
The 10th Leishmaniasis East Africa Platform (LEAP) meeting took place in Khartoum, Sudan. A solid clinical trial network is being built, thanks to the serious commitment of all members. Capacity building is still ongoing, with one site in Kenya to be built and another in Uganda to be strengthened. In May 2008, DNDi and its partners inaugurated a new treatment centre in Gondar, Ethiopia, with a 24 bed capacity.